Bio-Techne (TECH) Non Operating Income (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Non Operating Income of -$4.3 million in Q1 2026, down 16.13% quarter-over-quarter from -$3.7 million in Q4 2025, and down 883.87% on a YoY basis from $544732.5 in Q1 2025.
Bio-Techne (TECH) Non Operating Income (2009 - 2026) Analysis & Trends
Bio-Techne's Non Operating Income history runs 18 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 883.87% year-over-year to -$4.3 million; the TTM figure through Mar 2026 stood at -$6.6 million (down 291.24% YoY), while the FY2025 annual figure was -$3.8 million, up 55.82% from the prior year.
- Non Operating Income was -$4.3 million for Q1 2026 at Bio-Techne, down from -$3.7 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $47.4 million in Q3 2022 to a low of -$21.7 million in Q1 2022.
- Historically, Non Operating Income has averaged $254823.5 across 5 years, with a median of -$1.5 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income jumped 1039.13% in 2022, then slumped 39326.67% in 2024.
- A 5-year view of Non Operating Income shows it stood at -$1.5 million in 2022, then sank by 215.8% to -$4.6 million in 2023, then grew by 1.6% to -$4.5 million in 2024, then rose by 19.06% to -$3.7 million in 2025, then decreased by 16.13% to -$4.3 million in 2026.
- The last three Non Operating Income figures came in at -$4.3 million (Q1 2026), -$3.7 million (Q4 2025), and $333000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | -3.68 Mn |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | -434,000.00 |
| Dec 31, 2024 | -4.54 Mn |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 8.25 Mn |
| Mar 31, 2024 | -5.91 Mn |
| Dec 31, 2023 | -4.62 Mn |
| Sep 30, 2023 | -6.30 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | 47.40 Mn |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -21.68 Mn |
| Dec 31, 2021 | 23.83 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Jun 30, 2021 | -61.47 Mn |